Affiliation:
1. Division of Rheumatology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke
2. Department of Paediatrics, Faculty of Medicine and Health Sciences, University of Sherbrooke
Abstract
In overactive human osteoclasts, we previously identified an alternative splicing event inLGALS8, encoding galectin-8, resulting in decreased expression of the long isoform. Galectin-8, which modulates cell–matrix interactions and functions intracellularly as a danger recognition receptor, has never been associated with osteoclast biology. In human osteoclasts, inhibition of galectin-8 expression revealed its roles in bone resorption, osteoclast nuclearity, and mTORC1 signaling regulation. Galectin-8 isoform-specific inhibition asserted a predominant role for the short isoform in bone resorption. Moreover, a liquid chromatography with tandem mass spectrometry (LC-MS/MS) proteomic analysis of galectin-8 isoforms performed in HEK293T cells identified 22 proteins shared by both isoforms. Meanwhile, nine interacting partners were specific for the short isoform, and none were unique to the long isoform. Interactors specific for the galectin-8 short isoform included cell adhesion proteins and lysosomal proteins. We confirmed the interactions of galectin-8 with CLCN3, CLCN7, LAMP1, and LAMP2, all known to localize to secretory vesicles, in human osteoclasts. Altogether, our study reveals direct roles of galectin-8 in osteoclast activity, mostly attributable to the short isoform.
Funder
Canadian Government | Natural Sciences and Engineering Research Council of Canada
UDS | Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke
FRQ | Fonds de Recherche du Québec—Santé
Publisher
Life Science Alliance, LLC